HEADER NUCLEAR RECEPTOR 27-JUL-99 1QKN TITLE RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH TITLE 2 ANTAGONIST RALOXIFENE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: OESTROGEN RECEPTOR, ER-LBD; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: COMPLEXED WITH THE ANTAGONIST RALOXIFENE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: OESTROGEN RECEPTOR BETA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: GI724; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PLEX KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ANTAGONIST EXPDTA X-RAY DIFFRACTION AUTHOR A.C.W.PIKE,A.M.BRZOZOWSKI,M.CARLQUIST REVDAT 4 13-DEC-23 1QKN 1 REMARK REVDAT 3 24-JUL-19 1QKN 1 REMARK REVDAT 2 24-FEB-09 1QKN 1 VERSN REVDAT 1 28-JUL-00 1QKN 0 JRNL AUTH A.C.W.PIKE,A.M.BRZOZOWSKI,R.E.HUBBARD,T.BONN,A.-G.THORSELL, JRNL AUTH 2 O.ENGSTROM,J.LJUNGGREN,J.-A.GUSTAFFSON,M.CARLQUIST JRNL TITL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF OESTROGEN RECEPTOR JRNL TITL 2 BETA IN THE PRESENCE OF A PARTIAL AGONIST AND A FULL JRNL TITL 3 ANTAGONIST JRNL REF EMBO J. V. 18 4608 1999 JRNL REFN ISSN 0261-4189 JRNL PMID 10469641 JRNL DOI 10.1093/EMBOJ/18.17.4608 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.M.BRZOZOWSKI,A.C.W.PIKE,Z.DAUTER,R.E.HUBBARD,T.BONN, REMARK 1 AUTH 2 O.ENGSTROM,L.OHMAN,G.L.GREENE,J.-A.GUSTAFFSON,M.CARLQUIST REMARK 1 TITL MOLECULAR BASIS OF AGONISM AND ANTAGONISM IN THE OESTROGEN REMARK 1 TITL 2 RECEPTOR REMARK 1 REF NATURE V. 389 753 1997 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 9338790 REMARK 1 DOI 10.1038/39645 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 16870 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1691 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1750 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 128 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.59200 REMARK 3 B22 (A**2) : 3.59200 REMARK 3 B33 (A**2) : -6.69100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.244 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.220 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.014 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.038 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.044 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.012 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.136 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.182 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.335 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : 0.166 ; 0.300 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.000 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 18.400; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 32.900; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.183 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.430 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.516 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.754 ; 3.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT CORRECTION CALCULATED IN REMARK 3 XPLOR V3.843 WAS USED THROUGHOUT REFINEMENT. THE C-TERMINAL REMARK 3 HELIX (H12) IS VISIBLE BUT POORLY DEFINED IN THE ELECTRON REMARK 3 DENSITY MAPS. CONSEQUENTLY THIS REGION HAS EXTREMELY HIGH REMARK 3 TEMPERATURE FACTORS BUT ITS INCLUSION IN THE MODEL WAS REFLECTED REMARK 3 BY AN APPRECIABLE DROP IN FREE R FACTOR. REMARK 4 REMARK 4 1QKN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUL-99. REMARK 100 THE DEPOSITION ID IS D_1290002945. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-97 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9096 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16904 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ERE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.5% (W/V) PEG 4000, 0.1M AMMONIUM REMARK 280 ACETATE, 3% (W/V) DIMETHYLFORMAMIDE, 0.025M SODIUM ACETATE, PH REMARK 280 4.8, PH 4.80 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.10000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.05000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 111.15000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 74.10000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 111.15000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 37.05000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL_UNIT: DIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 67.55000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 67.55000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 37.05000 REMARK 400 REMARK 400 COMPOUND REMARK 400 BINDS ESTROGENS WITH AN AFFINITY SIMILAR TO THAT OF REMARK 400 ERALPHA, AND ACTIVATES EXPRESSION OF REPORTER GENES REMARK 400 CONTAINING ESTROGEN RESPONSE ELEMENTS (ERE) IN AN REMARK 400 ESTROGEN-DEPENDENT MANNER. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 210 REMARK 465 LYS A 211 REMARK 465 GLU A 212 REMARK 465 LEU A 213 REMARK 465 LEU A 214 REMARK 465 LEU A 215 REMARK 465 SER A 216 REMARK 465 CYS A 436 REMARK 465 LYS A 437 REMARK 465 ASN A 438 REMARK 465 VAL A 439 REMARK 465 VAL A 440 REMARK 465 PRO A 441 REMARK 465 VAL A 442 REMARK 465 TYR A 443 REMARK 465 HIS A 453 REMARK 465 LEU A 454 REMARK 465 THR A 455 REMARK 465 ARG A 456 REMARK 465 GLY A 457 REMARK 465 TYR A 458 REMARK 465 LYS A 459 REMARK 465 SER A 460 REMARK 465 SER A 461 REMARK 465 ILE A 462 REMARK 465 SER A 463 REMARK 465 GLY A 464 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 241 CB OG REMARK 470 PHE A 244 CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR A 245 OG1 CG2 REMARK 470 LYS A 255 CG CD CE NZ REMARK 470 ASP A 314 CG OD1 OD2 REMARK 470 GLU A 326 CG CD OE1 OE2 REMARK 470 LYS A 435 CG CD CE NZ REMARK 470 ASP A 444 CG OD1 OD2 REMARK 470 LEU A 445 CG CD1 CD2 REMARK 470 LEU A 447 CG CD1 CD2 REMARK 470 GLU A 448 CG CD OE1 OE2 REMARK 470 MET A 449 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 220 N - CA - CB ANGL. DEV. = 7.5 DEGREES REMARK 500 PRO A 232 CB - CA - C ANGL. DEV. = -16.2 DEGREES REMARK 500 PHE A 274 CB - CG - CD2 ANGL. DEV. = 4.8 DEGREES REMARK 500 ARG A 284 NH1 - CZ - NH2 ANGL. DEV. = -7.7 DEGREES REMARK 500 ARG A 284 NE - CZ - NH2 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG A 319 NE - CZ - NH2 ANGL. DEV. = -4.4 DEGREES REMARK 500 ASP A 333 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 ARG A 341 NE - CZ - NH1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 343 CD - NE - CZ ANGL. DEV. = 11.9 DEGREES REMARK 500 ARG A 343 NE - CZ - NH2 ANGL. DEV. = -5.2 DEGREES REMARK 500 LYS A 346 O - C - N ANGL. DEV. = -14.3 DEGREES REMARK 500 ALA A 371 CB - CA - C ANGL. DEV. = 9.4 DEGREES REMARK 500 GLU A 374 OE1 - CD - OE2 ANGL. DEV. = -8.2 DEGREES REMARK 500 GLU A 374 CG - CD - OE2 ANGL. DEV. = 14.9 DEGREES REMARK 500 ARG A 379 NE - CZ - NH2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP A 390 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG A 409 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 LEU A 410 CB - CG - CD2 ANGL. DEV. = -11.1 DEGREES REMARK 500 ARG A 421 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 243 132.43 -34.15 REMARK 500 THR A 245 -101.94 -86.37 REMARK 500 ALA A 247 -71.01 -58.64 REMARK 500 LEU A 315 77.21 -168.32 REMARK 500 GLU A 326 74.95 -65.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RAL A 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ERR RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 RALOXIFENE REMARK 900 RELATED ID: 1ERE RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 17BETA-ESTRADIOL REMARK 900 RELATED ID: 1QKM RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 PARTIAL AGONIST GENISTEIN DBREF 1QKN A 210 464 UNP Q62986 ESR2_RAT 255 509 SEQRES 1 A 255 VAL LYS GLU LEU LEU LEU SER THR LEU SER PRO GLU GLN SEQRES 2 A 255 LEU VAL LEU THR LEU LEU GLU ALA GLU PRO PRO ASN VAL SEQRES 3 A 255 LEU VAL SER ARG PRO SER MET PRO PHE THR GLU ALA SER SEQRES 4 A 255 MET MET MET SER LEU THR LYS LEU ALA ASP LYS GLU LEU SEQRES 5 A 255 VAL HIS MET ILE GLY TRP ALA LYS LYS ILE PRO GLY PHE SEQRES 6 A 255 VAL GLU LEU SER LEU LEU ASP GLN VAL ARG LEU LEU GLU SEQRES 7 A 255 SER CYS TRP MET GLU VAL LEU MET VAL GLY LEU MET TRP SEQRES 8 A 255 ARG SER ILE ASP HIS PRO GLY LYS LEU ILE PHE ALA PRO SEQRES 9 A 255 ASP LEU VAL LEU ASP ARG ASP GLU GLY LYS CYS VAL GLU SEQRES 10 A 255 GLY ILE LEU GLU ILE PHE ASP MET LEU LEU ALA THR THR SEQRES 11 A 255 SER ARG PHE ARG GLU LEU LYS LEU GLN HIS LYS GLU TYR SEQRES 12 A 255 LEU CYS VAL LYS ALA MET ILE LEU LEU ASN SER SER MET SEQRES 13 A 255 TYR PRO LEU ALA SER ALA ASN GLN GLU ALA GLU SER SER SEQRES 14 A 255 ARG LYS LEU THR HIS LEU LEU ASN ALA VAL THR ASP ALA SEQRES 15 A 255 LEU VAL TRP VAL ILE ALA LYS SER GLY ILE SER SER GLN SEQRES 16 A 255 GLN GLN SER VAL ARG LEU ALA ASN LEU LEU MET LEU LEU SEQRES 17 A 255 SER HIS VAL ARG HIS ILE SER ASN LYS GLY MET GLU HIS SEQRES 18 A 255 LEU LEU SER MET LYS CYS LYS ASN VAL VAL PRO VAL TYR SEQRES 19 A 255 ASP LEU LEU LEU GLU MET LEU ASN ALA HIS LEU THR ARG SEQRES 20 A 255 GLY TYR LYS SER SER ILE SER GLY HET ACT A 500 4 HET RAL A 600 34 HETNAM ACT ACETATE ION HETNAM RAL RALOXIFENE FORMUL 2 ACT C2 H3 O2 1- FORMUL 3 RAL C28 H27 N O4 S FORMUL 4 HOH *128(H2 O) HELIX 1 1 SER A 219 GLU A 231 1 13 HELIX 2 2 THR A 245 ILE A 271 1 27 HELIX 3 3 GLY A 273 LEU A 277 5 5 HELIX 4 4 SER A 278 ILE A 303 1 26 HELIX 5 5 ASP A 320 CYS A 324 5 5 HELIX 6 6 ILE A 328 LEU A 345 1 18 HELIX 7 7 GLN A 348 ASN A 362 1 15 HELIX 8 8 SER A 370 LYS A 398 1 29 HELIX 9 9 SER A 402 SER A 433 1 32 HELIX 10 10 LEU A 445 ALA A 452 1 8 SHEET 1 A 2 LYS A 308 ALA A 312 0 SHEET 2 A 2 LEU A 315 ASP A 318 -1 N LEU A 317 O LEU A 309 CISPEP 1 TYR A 366 PRO A 367 0 -6.07 SITE 1 AC1 5 THR A 382 ASN A 412 LEU A 416 HOH A2119 SITE 2 AC1 5 HOH A2127 SITE 1 AC2 14 LEU A 253 THR A 254 ALA A 257 ASP A 258 SITE 2 AC2 14 GLU A 260 LEU A 261 MET A 291 ARG A 301 SITE 3 AC2 14 PHE A 311 ILE A 331 GLY A 427 HIS A 430 SITE 4 AC2 14 LEU A 431 HOH A2014 CRYST1 67.550 67.550 148.200 90.00 90.00 90.00 P 41 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014804 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014804 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006748 0.00000